adalimumab,Etanercept
abbvie,amgen
[]
in ra pts initiating their first b/tsdmard, abs 1420 did not observe differences in 6- and 12-month effectiveness outcomes between etn, ada, and jaki monotherapy. #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.